6,7-Dichloro-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 50mg

4,6-Bis(3,5-di(pyridin-4-yl)phenyl)-2-phenylpyrimidine, 98%, 500mg

2-(4-METHYLPHENYL)-1,2-BENZISOTHIAZOL-3(2H)-ONE, 95.0%, 10mg

a-D-Xylopyranose, 95.0%, 1kg

1,6-Bis(4-carboxyphenoxy)hexane>96.0%(HPLC)(T)1g

6-Chloro-3-iodopyridin-2-ylamine, 95.0%, 100g

Dibenzo[a,e]cyclooctene>97.0%(GC)1g

2-(5-Bromo-2-chloro-pyrimidin-4-ylamino)-N-methyl-benzenesulfonamide, 98%, 250mg

3-Bromoquinolin-5-amine, 95.0%, 1g

5-Bromo-3-chloro-7h-pyrrolo[2,3-c]pyridazine, 97%, 5g

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)acetonitrile, 95.0%, 25g

3-Bromo-5-iodobenzotrifluoride, 97.0%, 1g

N,N-Dicyclohexylcarbodiimide (DCC), 250 g, >=98%, glass packaging